Understanding Women's Health: A More Comprehensive Assessment

The Complexity That Can Be Overlooked

Women’s health is not a single system. It is an intricate, constantly shifting conversation between multiple physiological factors, each of which influences the others. Oestrogen, progesterone, cortisol, thyroid function, insulin, and androgens do not operate in isolation. They form a dynamic network, and when one node shifts, the whole network responds [1].

This is not always how women’s health is assessed in practice. The conventional approach can tend to look at individual markers, against population-based reference ranges, at a single point in time. In some cases, a result that falls within “normal” may not tell the complete story. A more comprehensive assessment may provide additional clinical context.

For some women, this can be a familiar experience.

What “Normal” Actually Means

Reference ranges in pathology are derived from population studies. A result is considered normal if it falls within the range occupied by most people tested. That range is wide, and it includes a great deal of variation [2].

The consideration is that “normal” may not always reflect optimal. A woman can have oestrogen levels that are technically within the reference range and still experience symptoms that suggest physiological insufficiency. Thyroid function can fall squarely within normal parameters while the patient reports fatigue, feeling cold, and cognitive sluggishness [3]. Progesterone may be present at technically adequate levels, but if oestrogen is simultaneously elevated, the relative balance may be worth exploring further [4].

Women’s health requires interpretation, not just measurement. A number without context is of limited use.

The Role of Each Key Hormone

Oestrogen is often described as the primary female sex hormone, but this framing undersells its scope. It regulates bone density [5], cardiovascular function, skin integrity [6], cognitive clarity [7], and mood. Its levels fluctuate across the menstrual cycle, across the decade of perimenopause, and across life stages in ways that have profound downstream effects [4].

Progesterone works in balance with oestrogen. It supports sleep quality, calms the nervous system [8], and plays a central role in the second half of the menstrual cycle. When progesterone declines faster than oestrogen, which can occur during perimenopause, some women may experience disrupted sleep, anxiety, and irregular cycles [4, 9]. Standard testing may not always capture this imbalance, because each hormone, tested individually, may appear unremarkable.

Cortisol, the body’s primary stress-related factor, has a significant and often overlooked relationship with reproductive physiology [10]. Chronic elevation of cortisol, which can occur in women managing high workloads and sustained psychological pressure, may suppress progesterone production [11]. It can also influence thyroid function. A woman presenting with physiological symptoms may have a stress-cortisol factor that does not always appear on a standard health panel.

Thyroid function governs the metabolic rate of virtually every cell in the body. Thyroid dysfunction is significantly more common in women than in men [3], and its symptoms, including fatigue, weight changes, hair thinning, cognitive fog, and low mood, overlap substantially with symptoms of oestrogen and progesterone imbalance. Standard thyroid testing often measures only TSH, missing the more clinically informative picture that comes from assessing free T3, free T4, and thyroid antibodies together [2].

Why a Snapshot Is Not Enough

These levels fluctuate. Testing a woman’s oestrogen on day 20 of her cycle tells you something different from testing it on day 7. Testing progesterone outside the mid-luteal phase, when it should be at its peak, can produce a result that looks adequate but is, in context, low.

A female-first assessment accounts for this. It considers where a woman is in her cycle, her reproductive stage, her recent history of stress, her sleep patterns, and her subjective experience alongside her results. It also looks at the factors that are often left out of standard panels.

This kind of assessment does not fit neatly into a standard GP appointment. It requires time, clinical experience with female physiology, and a framework that centres the complexity of how female biology actually works.

What a Different Assessment Looks Like

A genuinely female-first assessment begins with a thorough history. Not a checklist, but a clinical conversation that maps symptom patterns across time, across the month, and across life stages.

It considers multiple physiological axes simultaneously. It looks at relative balance, not just absolute levels. It asks what the patient’s baseline feels like on good days, because “within normal range” is not the same as thriving.

From there, it designs a protocol that is individually considered, not templated. Because female female biology is not one-size-fits-all, and neither should clinical care be.

If you feel your concerns have not been fully addressed, a more comprehensive assessment may provide additional clinical context. This is a starting point for a clinical conversation, not a guarantee of any particular outcome.

---

Individual results vary based on your unique biology and commitment to the program. Assessment findings do not guarantee a particular outcome.

This article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare practitioner for advice specific to your circumstances.

References

1. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocrine Reviews. 1998;19(4):397-428. doi:10.1210/edrv.19.4.0341
2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism. 2002;87(2):489-499. doi:10.1210/jcem.87.2.8182
3. Biondi B, Cooper DS. Thyroid disease in women. Lancet Diabetes and Endocrinology. 2019;7(4):319-327. doi:10.1016/S2213-8587(18)30023-3
4. Prior JC. Progesterone for symptomatic perimenopause treatment: progesterone politics, physiology and potential for perimenopause. Facts, Views and Vision in ObGyn. 2011;3(2):109-120. PMID:24753856
5. Cauley JA. Estrogen and bone health in men and women. Steroids. 2015;99(Pt A):11-15. doi:10.1016/j.steroids.2014.12.010
6. Shah MG, Maibach HI. Estrogen and skin: an overview. American Journal of Clinical Dermatology. 2001;2(3):143-150. doi:10.2165/00128071-200102030-00003
7. Hara Y, Waters EM, McEwen BS, Morrison JH. Estrogen effects on cognitive and synaptic health over the lifecourse. Physiological Reviews. 2015;95(3):785-807. doi:10.1152/physrev.00036.2014
8. Caufriez A, Leproult R, L’Hermite-Baleriaux M, Kerkhofs M, Copinschi G. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. Journal of Clinical Endocrinology and Metabolism. 2011;96(4):E614-E623. doi:10.1210/jc.2010-2558
9. Schussler P, Kluge M, Yassouridis A, et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology. 2008;33(8):1124-1131. doi:10.1016/j.psyneuen.2008.05.013
10. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Annals of Internal Medicine. 1998;129(3):229-240. doi:10.7326/0003-4819-129-3-199808010-00012
11. Whirledge S, Cidlowski JA. A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary. Endocrinology. 2013;154(12):4450-4468. doi:10.1210/en.2013-1652